Cal-Maine Foods Inc (CALM) Shares Fall 3.3% -- GF Value Says Still Overvalued
Cal-Maine Foods Inc (CALM) shares fell 3.3% to $65.84, yet GuruFocus's GF Value™ still indicates the stock is 3.3% overvalued at $63.72, despite a strong GF Score™ of 74/100, primarily due to high financial strength. The company's P/E ratio is significantly above its historical median, suggesting inflated valuation, while insider buying activity contrasts with some guru trimming, adding complexity to its investment outlook. Investors are advised to exercise caution due to the current overvaluation and mixed signals from market indicators and expert actions.
Cal-Maine Shares Crack After Wider-Than-Expected Loss, Muted Egg Prices
Shares of Cal-Maine Foods Inc. dropped after the company reported wider-than-expected losses and soft first-quarter results for fiscal 2027. Analyst Pooran Sharma maintained an Equal-Weight rating but cut the price target due to lower gross margin, higher SG&A, and muted egg prices caused by industry supply imbalance, which is expected to persist through the holiday season. The company's net sales declined, and average selling prices for eggs fell significantly.
Cal-Maine Foods Shares Edge Lower After First-Quarter Loss and Revenue Miss
Cal-Maine Foods (NASDAQ:CALM) reported a wider-than-expected adjusted loss and revenue miss for its fiscal first quarter, with shares falling 1.54% in premarket trading. The company's revenue declined 41.5% year-on-year due to an industry supply imbalance affecting conventional shell egg sales. Cal-Maine also announced it would not pay a dividend for the first quarter, in line with its variable dividend policy.
Cal-Maine Foods stock edges down on first quarter loss and revenue miss
Cal-Maine Foods Inc. reported a first-quarter loss and revenue miss, with shares falling 1.54% in pre-market trading. The company's adjusted loss of $1.26 per share significantly exceeded the analyst consensus of $0.47, and revenue of $539.61 million missed estimates due to oversupply and a decline in conventional shell egg prices. Despite the downturn, Cal-Maine is strategically shifting towards higher-margin specialty shell eggs and prepared foods, which now account for a larger portion of net sales.
Cal-Maine Foods swings to loss in first quarter of fiscal 2027
Cal-Maine Foods reported a significant net loss of $58.6 million in the first quarter of fiscal 2027, a sharp decline from the previous year's net income. This loss was primarily attributed to a 59.3% drop in conventional shell egg prices due to an industry-wide oversupply. Despite the challenges, the company is diversifying its business, with Specialty Shell Eggs and Prepared Foods now accounting for 54.1% of net sales.
Cal-Maine Foods (CALM) Stock Faces Margin Crunch After Quarterly Loss
Cal-Maine Foods (CALM) reported a significant quarterly loss of US$58.6 million on reduced sales of US$539.6 million, primarily due to severe margin compression as gross profit nearly disappeared. Despite the company's efforts to shift towards specialty products and maintain a strong cash position, bearish investors point to weak egg fundamentals, rising costs, and legal risks, causing the stock to drop by 19% over 90 days. The current high P/E ratio of 54.4x on a slim 2.3% net margin raises questions about whether the stock is overvalued given its current profitability struggles.
Cal-Maine Foods: Why I'm Downgrading To Hold (NASDAQ:CALM)
Cal-Maine Foods (CALM) has been downgraded to Hold due to unexpectedly low profitability, primarily caused by a sharp drop in conventional egg prices. While the company's specialty and prepared foods segments performed well, the conventional egg sector experienced a deeply negative margin, raising concerns about operational efficiency despite a strong balance sheet and diversification efforts. The current valuation of CALM appears fair, but its near-term performance is contingent on the recovery of egg prices and improved execution.
Cal-Maine Foods Stock Cracks Under Egg-Industry Pressure - Cal-Maine Foods (NASDAQ:CALM)
Cal-Maine Foods (NASDAQ: CALM) shares are trading lower after the company reported weak first-quarter results, missing Wall Street estimates for both earnings and sales. The company's performance was impacted by a weak conventional egg cycle and investments in prepared foods, but it expects gradual stabilization and future earnings diversification from specialty eggs and prepared foods. As a result of a cumulative loss, Cal-Maine will not pay a cash dividend for the fiscal 2027 first quarter.
Cal-Maine Foods Q1 fiscal 2027 earnings loss
Cal-Maine Foods reported a significant net loss of $58.6 million in Q1 fiscal 2027, largely due to a 41.5% drop in net sales caused by an oversupply in the egg market and a sharp decline in conventional shell egg prices. The company's CEO, Sherman Miller, noted signs of potential cooling in flock growth but cautioned that improvement is not guaranteed. Consequently, Cal-Maine will not pay a dividend for the first quarter, and its stock saw a decline.
Cal-Maine Posts Another Quarterly Loss as Low Egg Prices Persist
Cal-Maine Foods reported another quarterly loss due to a persistent oversupply of eggs, which has significantly driven down wholesale prices. CEO Sherman Miller noted that wholesale egg prices dropped by nearly 60% in September. This market condition is negatively impacting the company's financial performance.
Cal-Maine Foods Reports 65.8% Wider Q1 2027 Loss at -$1.26/Share
Cal-Maine Foods (NASDAQ: CALM) reported a Q1 2027 diluted loss of $1.26 per share, significantly wider than the anticipated $0.76 loss, and revenue of $539.6M, falling below forecasts. The company's net loss was $58.6M, a stark reversal from the previous year's profitability, with revenue plunging 41.5% year-over-year due to industry headwinds and pressures in its Conventional Shell Eggs segment. Shares fell 3.5% following the announcement, as analysts maintain a mixed view on the stock.
What Cal-Maine Foods (CALM) Said on Its Q1 Earnings Call
Cal-Maine Foods reported a net loss in Q1 fiscal 2027 due to an oversupplied conventional egg market that pressured wholesale prices. The company is strategically investing in specialty eggs and prepared foods to diversify its earnings base, with a focus on expanding production capacity in prepared foods. Despite challenging market conditions, Cal-Maine highlighted constructive demand trends across retail, food service, and exports, and maintains a strong cash position to support its investments and growth initiatives.
Cheap Eggs Ahead of Election Season Weigh on US’s Top Producer
The US egg market is experiencing a period of low prices due to an oversupply and muted bird flu outbreaks, impacting the top producer, Cal-Maine Foods Inc. The company reported a significant 42% drop in net sales for its fiscal first quarter, indicating a struggle to navigate the current market conditions. This trend of cheap eggs is expected to continue.
Cal-Maine Foods Q1: A Weak Quarter, But Supply Rationalization Offers Hope (NASDAQ:CALM)
Cal-Maine Foods reported a weak first quarter with revenue down 41% year-over-year and an EPS of -$1.26, missing consensus estimates. Despite widespread segment weakness, signs of egg price normalization and supply rationalization suggest a potential cyclical upturn for the company. With a strong balance sheet, ongoing M&A and CapEx, and an EV-to-Sales ratio below 1x, the author maintains a Buy rating for CALM, anticipating a long-term shareholder yield potential exceeding 9%.
Cal-Maine Foods Reports First Quarter Fiscal 2027 Results
Cal-Maine Foods reported significant declines in net sales, gross profit, and net income for its first quarter of fiscal 2027, primarily due to lower conventional shell egg pricing. Despite the challenging market for conventional eggs, the company highlighted growth in its Specialty Shell Eggs and Prepared Foods segments, which now account for 54.1% of net sales. Cal-Maine Foods is focusing on strategic investments in Prepared Foods capacity and aims to build a more diversified and durable earnings profile, though no cash dividend will be paid for the quarter.
Cal-Maine earnings on deck amid weak egg pricing, cost pressure
Cal-Maine Foods Inc. is set to report its first-quarter fiscal 2027 results, with analysts anticipating a narrower loss despite challenges from industry oversupply and rising production costs. The company faces depressed shell egg prices and accelerating input costs, leading to recent downgrades by analysts who expect fundamental weakness. Investors will focus on the company's efforts to stabilize margins, the industry's response to oversupply, and Cal-Maine's strategic shift towards higher-margin specialty eggs.
Speria - MTech Systems Announces Partnership with Cal-Maine to Modernize Financial Reporting and Strengthen Operational Visibility
Speria - MTech Systems has partnered with Cal-Maine Foods, Inc. to implement its Amino solution, aiming to modernize Cal-Maine's financial and flock management operations. The integration of Amino, which connects operational and financial processes and integrates with SAP, will enhance reporting flexibility, streamline data flow, and reduce reliance on manual reporting. This collaboration is expected to provide Cal-Maine with better real-time visibility and a modern foundation for its evolving operations.
Cal-Maine (CALM) Q3 Earnings: What To Expect
Cal-Maine Foods (NASDAQ:CALM) is set to announce its Q3 earnings this Wednesday, with analysts expecting a 39.1% year-on-year revenue decline. The company missed revenue and EPS estimates last quarter, and its stock has underperformed the consumer staples segment recently. Despite this, analysts have largely reconfirmed their estimates, with an average price target of $75 against a current share price of $67.34.
Is Cal-Maine Foods (CALM) Undervalued As Its Shares Slide And P/E Sends Mixed Signals?
Cal-Maine Foods (CALM) shares recently slipped, with a 30-day drop of 18.61% and a 1-year total shareholder return down 27.68%, despite being assessed as 15.5% undervalued with an $81 fair value. However, its P/E ratio of 10.1x is below the industry average but above its own fair ratio of 5.5x, creating mixed signals for investors. The company's valuation relies on assumptions of expanding specialty egg offerings and margin expansion, but also faces risks from egg oversupply or avian influenza.
Cal-Maine Foods may see 6.7% move on Sept. 30 earnings
Cal-Maine Foods Inc. (CALM) shares are predicted to move 6.7% when the company releases its earnings report on September 30, according to options data. The stock has historically moved close to its options-implied amount in past earnings announcements, though with some variability. For example, in its most recent report, the stock moved 5.7% against a 7.5% implied move.
Stephens cuts Cal-Maine Foods stock price target on weak demand
Stephens has lowered its price target for Cal-Maine Foods (NASDAQ:CALM) to $80 from $90, while maintaining an Equal Weight rating, due to weaker-than-anticipated demand in the U.S. egg market despite seasonal expectations. The firm noted that back-to-school and fall baking demand has been soft, though holiday demand in November and December could improve the fundamental backdrop. Cal-Maine recently reported a significant fourth-quarter loss, missing Wall Street forecasts, attributed to an oversupply in the egg market and historically low conventional shell egg prices, even as Benchmark reiterated a Buy rating with a $100 price target.
Cal-Maine Foods stock hits 52-week low at $71.91
Cal-Maine Foods Inc. (CALM) stock recently hit a 52-week low of $71.91, trading nearly 29% below its high. This decline is attributed to an oversupply in the egg market leading to historically low prices, resulting in a significant fourth-quarter loss and revenue falling short of expectations. Despite the downturn, some analysts believe the stock may be oversold and undervalued.
Stephens cuts Cal-Maine Foods stock price target on weak demand
Stephens has lowered its price target for Cal-Maine Foods (NASDAQ:CALM) to $80 from $90, citing weak demand in the U.S. egg market despite seasonal trends. The firm noted that back-to-school demand was softer than expected and holiday baking demand has yet to materialize, although the fundamental outlook could improve through November and December. This downgrade comes after Cal-Maine reported a significant quarterly loss due to egg oversupply and low prices, even as Benchmark reiterated a Buy rating on the stock.
I Just Bought Cal-Maine Foods (CALM) At $71.74 (NASDAQ:CALM)
The author purchased shares of Cal-Maine Foods (CALM) at $71.74, citing the company's high ranking on the BTMA Stock Analyzer. The investment decision was based on Cal-Maine Foods' strong balance sheet, significant cash reserves, absence of long-term debt, and its stock trading near its 52-week low. The company is a leading producer and distributor of fresh shell eggs in the USA.
(CALM) Risk Channels and Responsive Allocation
This article provides an AI-driven analysis for Cal-Maine Foods Inc. (NASDAQ: CALM), highlighting a near-term neutral sentiment with a mid-channel oscillation pattern. It outlines three distinct trading strategies (Position, Momentum Breakout, Risk Hedging) tailored for different risk profiles, offering specific entry, target, and stop-loss levels. The analysis also presents multi-timeframe signal analysis with identified support and resistance levels.
CALM - Cal-Maine Foods Inc Volatility & Greeks
This article provides a detailed financial overview of Cal-Maine Foods Inc (CALM), including its stock performance, key financial ratios, and insider/institutional ownership. It highlights volatility metrics, various earnings and sales figures, and analyst recommendations. The data presented covers market capitalization, dividend information, and short interest, offering a comprehensive snapshot of the company's financial health and market position.
Cal-Maine Foods Schedules First Quarter Fiscal 2027 Earnings Release, Conference Call and Webcast
Cal-Maine Foods, Inc. announced that it will report its first quarter fiscal 2027 results on Wednesday, September 30, 2026, at approximately 6:00 a.m. ET. The company will also host a conference call and webcast at 9:00 a.m. ET on the same day to review the results. Interested parties can access the earnings release and webcast details on the Cal-Maine Foods investor relations website.
Cal-Maine Foods Announces Fiscal 2027 First Quarter Earnings Release and Conference Call Schedule
Cal-Maine Foods, Inc. (Nasdaq: CALM) will report its fiscal 2027 first quarter results on September 30, 2026, at 6:00 a.m. ET, followed by a conference call and webcast at 9:00 a.m. ET. The earnings release and webcast access details will be available on the company's investor relations website. The company, the largest egg producer in the U.S., aims to maintain transparency with investors regarding its operational performance and market presence.
Cal-Maine Foods Schedules First Quarter Fiscal 2027 Earnings Release, Conference Call and Webcast
Cal-Maine Foods, Inc. (Nasdaq: CALM) announced it will release its first quarter fiscal 2027 earnings results on Wednesday, September 30, 2026, at approximately 6:00 a.m. ET. A conference call and webcast will follow at 9:00 a.m. ET on the same day for management to review the results. The company, the largest egg company in the United States, will make the earnings release and webcast replay available on its investor relations website.
America's largest egg company will report results Sept. 30
Cal-Maine Foods (CALM), the largest egg company in the United States, announced it will release its fiscal 2027 first-quarter results on Wednesday, September 30, 2026, at approximately 6:00 a.m. ET. Management will host a conference call and live webcast at 9:00 a.m. ET on the same day to discuss the results. The earnings release and webcast details will be available on the company's investor relations website, with options for telephone registration to join the call.
Weekly Recap: Cal-Maine Foods, Inc. credit amendment and StoneX downgrade
Cal-Maine Foods, Inc. (CALM) is transitioning from a shell-egg producer to a diversified egg and egg-based foods company through strategic investments and acquisitions. The company recently amended its credit agreement, securing a $250M senior unsecured revolving credit facility. StoneX downgraded Cal-Maine Foods' rating from Buy to Hold.
Here Are Friday’s Top Wall Street Analyst Research Calls: Ambarella, Cal-Maine Foods, Lennar, Ormat Technologies, Paychex, PulteGroup, Shell plc, TotalEnergies, W.P. Carey, and More
This article details Wall Street's top analyst upgrades, downgrades, and initiations for Friday, September 4, 2026, featuring companies like Shell PLC, Ambarella, PulteGroup, and Lennar. It also provides a market recap for the week, noting a broad rally sparked by Fed Governor Waller's signal to hold rates steady, which pushed the Nasdaq higher and Bitcoin above $80,000. The report includes key market data on treasury bonds, oil, gold, and crypto, alongside specific analyst actions for various stocks.
Precision Trading with Cal-maine Foods Inc. (CALM) Risk Zones
This article provides an AI-generated analysis for Cal-maine Foods Inc. (CALM), highlighting near-term weak sentiment and a significant 44.4:1 risk-reward setup. It outlines three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, support, and resistance levels for traders.
Cal-Maine Foods (CALM) Stock Looks Overvalued On Cash Flow And Earnings
The article from Sahm Capital Financial Company, titled "Cal-Maine Foods (CALM) Stock Looks Overvalued On Cash Flow And Earnings," is currently displaying a 404 error, indicating that the intended content is unavailable. The page only contains navigation, company information, and legal disclaimers.
Cal-Maine Foods (CALM) Stock Looks Overvalued On Cash Flow And Earnings
Cal-Maine Foods (CALM) stock appears overvalued based on both Discounted Cash Flow (DCF) intrinsic value estimates and P/E ratio analysis. Despite a strong 204.6% return over the past 5 years, current valuations suggest the shares trade at a premium, with the DCF model indicating an 11.9% overvaluation and the P/E ratio exceeding the model's fair value. The article questions if the company can sustain cash flows and earnings to justify this premium, especially if egg pricing or margins face pressure.
Cal-Maine Foods Jumps 5.3% Amid Sector-Wide Rally
Cal-Maine Foods, Inc. (CALM) saw its stock surge by 5.3% on Monday, closing at $87.22, as part of a broad sector-wide rally in farm products. This increase was not company-specific but indicative of a larger market rotation, with other sector peers also experiencing solid gains. The coordinated movement and increased trading volume suggest institutional interest and potential shifts in investor sentiment towards the farm products industry.
Cal-Maine Foods Q4 revenue drops 49.9% as egg prices fall, but specialty products boost resilience
Cal-Maine Foods experienced a 49.9% year-over-year revenue decline in Q4 2026 due to falling conventional egg prices. However, the company has diversified its portfolio, with specialty eggs and prepared foods now accounting for 53% of net sales, lessening its dependence on the volatile conventional egg market. Despite ongoing cyclical risks, the company's strong cash reserves and capital management indicate a positive outlook, especially as egg prices begin to recover.
CAL-MAINE FOODS INC SEC Filing (Aug 18, 2026)
This article reports on a CAL-MAINE FOODS INC (CALM) SEC filing of type ARS that occurred on August 18, 2026. The filing was accepted by the SEC EDGAR system at 04:21 PM on that date. It provides details about the filing's impact and sentiment, and links to the full PDF document on the SEC EDGAR website.
Cal-Maine Foods (CALM) sees American Century, Stowers report 5.3% stake
American Century entities and the Stowers Institute for Medical Research have reported beneficial ownership of over 5% of Cal-Maine Foods' common stock through a Schedule 13G filing. American Century ETF Trust holds 5.1% of common stock, while American Century Investment Management, American Century Companies, and Stowers Institute each beneficially own 5.3%. The filing details their sole voting and dispositive power over these shares, clarifying that no single client advised by American Century Investment Management owns more than 5%.
Bank of America Corp DE Raises Holdings in Cal-Maine Foods, Inc. $CALM
Bank of America Corp DE significantly increased its stake in Cal-Maine Foods, Inc. (NASDAQ:CALM) by 21.9% in the first quarter, now owning over 505,000 shares valued at approximately $40 million. Other institutional investors also adjusted their positions in the company, which reported a quarterly loss and a revenue decline of 49.9% year-over-year. Analyst sentiment for Cal-Maine Foods remains mixed, with a consensus "Hold" rating and an average price target of $94.71.
Royal Bank of Canada Decreases Stake in Cal-Maine Foods, Inc. $CALM
Royal Bank of Canada reduced its stake in Cal-Maine Foods, Inc. (NASDAQ:CALM) by 16.5% during the first quarter, selling 31,212 shares and retaining 158,508 shares valued at $12.5 million. This reduction comes as institutional investors collectively own 84.67% of the company, and Cal-Maine Foods reported a significant earnings decline with a quarterly loss of $0.76 per share, missing analyst expectations. Despite a cautious outlook from analysts, the stock trades with an average price target of $94.71 against a recent price of $85.08.
Cal-Maine Foods, Inc. (CALM) Stock Forecasts
An Argus report from August 5, 2026, has decreased its rating for Cal-Maine Foods Inc. (CALM) to a HOLD. The report provides a summary of the company, which produces and sells shell eggs primarily in the United States, and offers a current price of $82.43. To access the full report and further insights, users are encouraged to upgrade to Yahoo Finance Silver.
Cal Maine Foods (CALM) Could Be 2% Undervalued If Its Capital Returns Story Holds
Cal-Maine Foods (CALM) shares recently closed at US$85.08 and are considered 1.9% undervalued with a fair value of $86.75, based on strong cash generation, a debt-free balance sheet, and a capital allocation framework including share repurchases. While the company has shown strong long-term momentum, with 3-year and 5-year returns of 111% and 216% respectively, it faces risks such as avian influenza and potential softening demand for specialty egg products. The stock's P/E ratio of 12.6x is below the US market and food industry averages, but above its suggested fair ratio of 8.4x.
Cal-Maine Foods, Inc. (NASDAQ:CALM) Receives Average Recommendation of "Hold" from Analysts
Cal-Maine Foods, Inc. (NASDAQ:CALM) has received an average "Hold" recommendation from five analysts, with a consensus 1-year price target of $94.71. The company's stock is currently trading around $85.08, and institutional investors own 84.67% of its shares. Cal-Maine Foods recently missed earnings expectations, reporting a loss of $0.76 per share against an anticipated profit of $0.08, with revenue down 49.9% year-over-year.
Cal Maine Foods (CALM) Could Be 2% Undervalued If Its Capital Returns Story Holds
Cal-Maine Foods (CALM) shares recently closed at US$85.08 and are considered about 1.9% undervalued with a fair value of $86.75, based on strong cash generation, a debt-free balance sheet, and a capital allocation framework including share repurchases. Despite this, the company faces risks from avian influenza and potential softening demand for premium egg products. While its P/E ratio of 12.6x is below the US market and food industry averages, it's above its suggested fair ratio of 8.4x.
Cal-Maine denies any wrongdoing in egg price-fixing settlement
Cal-Maine Foods Inc. has agreed to a $1.5 million payment and a donation of 30 million eggs to settle antitrust claims alleging manipulation of egg prices nationwide. Despite the settlement, Cal-Maine denies any wrongdoing, stating that the communications cited by the DOJ were primarily from a single former employee and did not impact egg prices. The settlement has been criticized by antitrust watchdogs for its relatively small financial penalty compared to the alleged profits garnered by the companies involved.
Cal-Maine denies any wrongdoing in egg price-fixing settleme...
Cal-Maine Foods Inc., the largest egg producer in the nation, has agreed to a $1.5 million settlement and will donate 30 million eggs to resolve antitrust claims regarding egg price manipulation. Despite the settlement, Cal-Maine denies any wrongdoing, attributing communications cited in the federal complaint to a single former employee and stating that the alleged actions did not impact egg prices. The settlement has faced criticism for its relatively small financial penalty compared to the companies' profits during the alleged scheme, and it has brought renewed attention to a stock sale by Cal-Maine's founding family shortly after the Justice Department's investigation began.
Cetera Investment Advisers Boosts Stock Position in Cal-Maine Foods, Inc. $CALM
Cetera Investment Advisers significantly increased its stake in Cal-Maine Foods by 36.3% in the first quarter, now owning 44,621 shares valued at $3.5 million. This increase comes despite the company reporting a weak quarter with a loss of $0.76 per share and a 49.9% year-over-year revenue decline. Analysts maintain a cautious outlook, with a consensus "Hold" rating and an average price target of $94.71.
Cal-Maine Foods, Inc. (CALM) Stock Price, News, Quote & History
This Yahoo Finance article provides a comprehensive overview of Cal-Maine Foods, Inc. (CALM), including its current stock price, recent performance metrics, and key financial data. It details the company's operations in shell eggs and prepared foods, lists its various brands, and presents analyst insights along with performance comparisons against the S&P 500. The article serves as a detailed resource for investors tracking CALM.
Pacer Advisors Inc. Has $28.82 Million Stock Holdings in Cal-Maine Foods, Inc. $CALM
Pacer Advisors Inc. reduced its stake in Cal-Maine Foods, Inc. by 13.1% in the first quarter, now holding 364,110 shares valued at $28.82 million. This comes as Cal-Maine Foods reported a significant quarterly loss of $0.76 per share, missing analyst expectations, with revenue down 49.9% year over year. Analysts currently maintain a "Hold" rating on the stock, with an average price target of $94.71.
